Otto Prümmer

1.4k total citations
42 papers, 798 citations indexed

About

Otto Prümmer is a scholar working on Genetics, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Otto Prümmer has authored 42 papers receiving a total of 798 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 11 papers in Immunology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Otto Prümmer's work include Hematopoietic Stem Cell Transplantation (8 papers), Mesenchymal stem cell research (8 papers) and Lymphoma Diagnosis and Treatment (7 papers). Otto Prümmer is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), Mesenchymal stem cell research (8 papers) and Lymphoma Diagnosis and Treatment (7 papers). Otto Prümmer collaborates with scholars based in Germany, Switzerland and Italy. Otto Prümmer's co-authors include Theodor M. Fliedner, Franz Porzsolt, Jung-Hun Lee, Brigitte Rüster, Günter Herrmann, Kurt W. Roth, Stefan Zeuzem, Alexa Franke, W. Calvo and Aruna Raghavachar and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Development.

In The Last Decade

Otto Prümmer

42 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Otto Prümmer Germany 16 239 228 215 190 149 42 798
Federico Silvestri Italy 13 96 0.4× 230 1.0× 133 0.6× 224 1.2× 51 0.3× 30 632
S Sugai Japan 10 237 1.0× 102 0.4× 117 0.5× 48 0.3× 72 0.5× 31 592
S. Ferenčík Germany 15 646 2.7× 110 0.5× 258 1.2× 173 0.9× 225 1.5× 40 1.2k
Chantal André France 16 110 0.5× 402 1.8× 358 1.7× 89 0.5× 287 1.9× 29 1.2k
Felicia Anna Tucci Italy 15 194 0.8× 718 3.1× 381 1.8× 287 1.5× 378 2.5× 24 1.1k
F Silvestri Italy 17 123 0.5× 329 1.4× 168 0.8× 269 1.4× 48 0.3× 41 941
Pietro Gatti Italy 17 108 0.5× 551 2.4× 332 1.5× 131 0.7× 189 1.3× 36 883
Pascale Loiseau France 22 753 3.2× 101 0.4× 210 1.0× 190 1.0× 303 2.0× 45 1.6k
Giuseppe Iodice Italy 15 118 0.5× 268 1.2× 213 1.0× 85 0.4× 44 0.3× 31 875
Allison Luo United States 13 416 1.7× 60 0.3× 307 1.4× 80 0.4× 343 2.3× 30 1.0k

Countries citing papers authored by Otto Prümmer

Since Specialization
Citations

This map shows the geographic impact of Otto Prümmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Otto Prümmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Otto Prümmer more than expected).

Fields of papers citing papers by Otto Prümmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Otto Prümmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Otto Prümmer. The network helps show where Otto Prümmer may publish in the future.

Co-authorship network of co-authors of Otto Prümmer

This figure shows the co-authorship network connecting the top 25 collaborators of Otto Prümmer. A scholar is included among the top collaborators of Otto Prümmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Otto Prümmer. Otto Prümmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walz, Christoph, Georgia Metzgeroth, Claudia Haferlach, et al.. (2007). Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor   gene. Haematologica. 92(2). 163–169. 60 indexed citations
2.
Zeuzem, Stefan, Jung-Hun Lee, Alexa Franke, et al.. (1998). Quantification of the initial decline of serum hepatitis c virus RNA and response to interferon alfa. Hepatology. 27(4). 1149–1156. 142 indexed citations
3.
Ellenrieder, Volker, H Weidenbach, Norbert Frickhofen, et al.. (1998). HCV and HGV in B-cell non-Hodgkin's lymphoma. Journal of Hepatology. 28(1). 34–39. 72 indexed citations
4.
Prümmer, Otto. (1997). Treatment-induced antibodies to interleukin-2. Biotherapy. 10(1). 15–24. 33 indexed citations
5.
6.
Prümmer, Otto, Christoph Fiehn, & Harald Gallati. (1996). Anti-Interferon-γ Antibodies in a Patient Undergoing Interferon-γ Treatment for Systemic Mastocytosis. Journal of Interferon & Cytokine Research. 16(7). 519–522. 10 indexed citations
7.
Prümmer, Otto, Detlef Zillikens, & Franz Porzsolt. (1996). High‐titer interferon‐α antibodies in a patient with pemphigus foliaceus. Experimental Dermatology. 5(4). 213–217. 9 indexed citations
8.
Weber, C., W. Florian, Elmar M. Merkle, et al.. (1996). Reversible metastatic pulmonary calcification in a patient with multiple myeloma. Annals of Hematology. 72(5). 329–332. 22 indexed citations
9.
Fiehn, Christoph, Otto Prümmer, H. Gallati, B. Heilig, & W. Hunstein. (1995). Treatment of systemic mastocytosis with interferon‐γ: failure after appearance of anti‐IFN‐γ antibodies. European Journal of Clinical Investigation. 25(8). 615–618. 19 indexed citations
10.
Prümmer, Otto, et al.. (1994). Recombinant Interferon-α 2 Antibodies in Renal Cell Carcinoma. Journal of Interferon Research. 14(4). 193–195. 3 indexed citations
11.
Wussow, Peter von, R. Hehlmann, D Jakschies, et al.. (1994). Roferon (rIFN-α 2a ) Is More Immunogenic Than Intron A (rIFN-α 2b ) in Patients with Chronic Myelogenous Leukemia. Journal of Interferon Research. 14(4). 217–219. 24 indexed citations
12.
Prümmer, Otto, et al.. (1994). Capillary leak syndrome associated with elevated IL-2 serum levels after allogeneic bone marrow transplantation. Annals of Hematology. 68(1). 49–52. 19 indexed citations
13.
Prümmer, Otto, et al.. (1994). Sensitive antiproliferative neutralization assay for the detection of neutralizing IFN-α and IFN-β antibodies. Journal of Immunological Methods. 171(1). 45–53. 10 indexed citations
14.
Funke, I., et al.. (1994). Subcutaneous IL-2 and Low-Dose IFN-α2a in the Treatment of Unselected Patients with Advanced Renal Cell Cancer. Oncology Research and Treatment. 17(3). 263–269. 4 indexed citations
15.
Prümmer, Otto, Norbert Frickhofen, W. Digel, H. Heimpel, & Franz Porzsolt. (1991). Spontaneous interferon-α antibodies in a patient with pure red cell aplasia and recurrent cutaneous carcinomas. Annals of Hematology. 62(2-3). 76–80. 16 indexed citations
16.
Ho, Anthony D., J. Thaler, Franco Mandelli, et al.. (1989). Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.. Journal of Clinical Oncology. 7(10). 1533–1538. 52 indexed citations
17.
Prümmer, Otto, W. Calvo, & Theodor M. Fliedner. (1987). Variation of treatment conditions alters the outcome of fetal liver transplantation in dogs. PubMed. 10(1-2). 19–31. 3 indexed citations
18.
Ho, Anthony D., R. Kuse, Otto Prümmer, Franz Porzsolt, & W. Hunstein. (1987). 2′-Deoxycoformycin (pentostatin) in hairy cell leukemia: Response in patients refractory to interferon alpha. Journal of Molecular Medicine. 65(20). 975–979. 7 indexed citations
19.
Prümmer, Otto, et al.. (1985). Fetal liver transplantation in the dog. I. Restoration of hemopoiesis with cryopreserved fetal liver cells from DLA-identical siblings.. PubMed. 39(4). 349–55. 9 indexed citations
20.
Raghavachar, Aruna, et al.. (1983). Stem cells from peripheral blood and bone marrow: A comparative evaluation of the hemopoietic potential in the dog. The International Journal Of Cell Cloning. 1(4). 191–205. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026